Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery

Today 17:18 EDT

Via MarketMinute

Moment of Clarity Publishes Comprehensive New Resource on Website Discussing Proper Spravato Dosing During Treatment and Clinical Oversight Standards

Today 15:28 EDT

Via Press Advantage

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug ↗

Today 13:35 EDT

Via Benzinga

Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application ↗

Today 12:42 EDT

Via Benzinga

Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office

Today 11:30 EDT

Via Newsfile

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

Today 11:10 EDT

Via NewMediaWire

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

Today 11:10 EDT

Via TheNewswire.com

The Great Decoupling: Western Digital’s Strategic Bet on the HDD Renaissance

Today 9:59 EDT

Via Finterra

Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis

Today 9:52 EDT

Via Finterra

Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients ↗

Today 9:42 EDT

Via Benzinga

Dollar Tree (DLTR) Deep-Dive: The Multi-Price Transformation and Post-Divestiture Outlook

Today 9:41 EDT

Via Finterra

Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks ↗

Today 9:20 EDT

Via The Motley Fool

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting NDA Review For NRX-100

Today 9:15 EDT

Via Investor Brand Network

HeartBeam Inc. (NASDAQ: BEAT) Featured in Coverage of the 38th Annual ROTH Conference

Today 9:05 EDT

Via Investor Brand Network

Cingulate Stock Jumps Overnight: US Patent Office Clears ADHD Drug Filing Ahead Of May FDA Catalyst ↗

March 15, 2026

Via Stocktwits

uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline

March 14, 2026

Via TheNewswire.com

uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline

March 14, 2026

Via NewMediaWire

Is Ford Stock a Buy Now? ↗

March 14, 2026

Via The Motley Fool

SLNO ALERT: Securities Class Action Lawsuit Against Soleno Therapeutics, Inc. (SLNO) - Contact Kaplan Fox Before Deadline on May 5, 2026

March 14, 2026

Via NewMediaWire

SLNO ALERT: Securities Class Action Lawsuit Against Soleno Therapeutics, Inc. (SLNO) - Contact Kaplan Fox Before Deadline on May 5, 2026

March 14, 2026

Via TheNewswire.com

Must the expiration date of pharmaceutical packaging materials cover the expiration date of the drug?

March 13, 2026

Via AB Newswire

CAPR Stock Slumps But Wall Street Reiterates Optimism For Deramiocel Approval ↗

March 13, 2026

Via Stocktwits

Toyota Hit By Major US Recall Of 550,000 SUVs ↗

March 13, 2026

Via Benzinga

FDA Broadens Access To GSK's Respiratory Syncytial Virus Shot For Younger High-Risk Adults ↗

March 13, 2026

Via Benzinga

Driving Change with Rapid Prototyping in Automotive Manufacturing

March 13, 2026

Via AB Newswire

Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives

March 13, 2026

Via NewMediaWire

Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives

March 13, 2026

Via TheNewswire.com

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗

March 13, 2026

Via The Motley Fool

Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗

March 13, 2026

Via The Motley Fool

SLNO CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Lead Plaintiff Deadline on May 5, 2026

March 13, 2026

Via NewMediaWire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.